MONTPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MONTPHARMA
Largest movements
- Cash +€51,020
up €51,020 (+73.3%), from €69,564 to €120,584
mainly Net result for the year (+€41,561) and Tax, wage and social debts (+€12,307)
- Receivables within one year +€4,103
up €4,103 (+42.6%), from €9,623 to €13,726
of which Other amounts receivable: +€4,727
- Deferred charges and accrued income -€2,713
no longer reported in 2025 (was €2,713)
- Profit (loss) carried forward +€40,728
up €40,728 (+60.1%), from €67,731 to €108,460
- Tax, wage and social debts +€12,307
up €12,307 (+130.9%), from €9,398 to €21,705
- Trade debts -€1,780
down €1,780 (-63.7%), from €2,793 to €1,013
- Gross operating margin -€33,443
down €33,443 (-37.8%), from €88,530 to €55,087
- Taxes -€6,603
down €6,603 (-37.6%), from €17,556 to €10,953
- Financial charges -€1,786
down €1,786 (-83.9%), from €2,128 to €342
- Staff costs +€1,457
new in 2025: €1,457
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €83,782 | €135,487 | +€51,705 | +61.7% |
| Fixed assets | 21/28 | €1,883 | €1,177 | -€706 | -37.5% |
| Tangible fixed assets | 22/27 | €1,883 | €1,177 | -€706 | -37.5% |
| Furniture and vehicles | 24 | €1,883 | €1,177 | -€706 | -37.5% |
| Current assets | 29/58 | €81,899 | €134,310 | +€52,410 | +64.0% |
| Amounts receivable within one year | 40/41 | €9,623 | €13,726 | +€4,103 | +42.6% |
| Trade receivables | 40 | €9,619 | €8,994 | -€624 | -6.5% |
| Other amounts receivable | 41 | €4 | €4,731 | +€4,727 | +118187.0% |
| Cash at bank and in hand | 54/58 | €69,564 | €120,584 | +€51,020 | +73.3% |
| Deferred charges and accrued income | 490/1 | €2,713 | - | -€2,713 | |
| Total equity and liabilities | 10/49 | €83,782 | €135,487 | +€51,705 | +61.7% |
| Equity | 10/15 | €70,731 | €111,460 | +€40,728 | +57.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €67,731 | €108,460 | +€40,728 | +60.1% |
| Amounts payable | 17/49 | €13,051 | €24,027 | +€10,976 | +84.1% |
| Amounts payable within one year | 42/48 | €13,051 | €24,027 | +€10,976 | +84.1% |
| Trade debts | 44 | €2,793 | €1,013 | -€1,780 | -63.7% |
| Suppliers | 440/4 | €2,793 | €1,013 | -€1,780 | -63.7% |
| Taxes, remuneration and social security | 45 | €9,398 | €21,705 | +€12,307 | +130.9% |
| Taxes | 450/3 | €9,398 | €21,705 | +€12,307 | +130.9% |
| Other amounts payable | 47/48 | €859 | €1,309 | +€450 | +52.4% |
| Remuneration, social security and pensions | 62 | - | €1,457 | +€1,457 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €256 | €706 | +€450 | +175.6% |
| Other operating charges | 640/8 | - | €69 | +€69 | |
| Gross operating margin | 9900 | €88,530 | €55,087 | -€33,443 | -37.8% |
| Operating profit (loss) | 9901 | €88,274 | €52,855 | -€35,419 | -40.1% |
| Financial charges | 65/66B | €2,128 | €342 | -€1,786 | -83.9% |
| Recurring financial charges | 65 | €2,128 | €342 | -€1,786 | -83.9% |
| Profit (loss) for the period before taxes | 9903 | €86,146 | €52,514 | -€33,633 | -39.0% |
| Income taxes | 67/77 | €17,556 | €10,953 | -€6,603 | -37.6% |
| Profit (loss) for the period | 9904 | €68,590 | €41,561 | -€27,029 | -39.4% |
| Profit (loss) for the period to be appropriated | 9905 | €68,590 | €41,561 | -€27,029 | -39.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.